secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001493152-24-015713
Event type: regulatory
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants Biotricity continued listing subject to milestones by July 29, 2024
--------------------------------------------------------------------------------

- Panel granted listing continuation after hearing on April 9, 2024.
- Conditions include increasing outstanding shares via stock offerings and convertible conversions.
- Company must receive shareholder approval for certain actions.
- Biotricity must regain compliance with all Nasdaq listing requirements by July 29, 2024.
- Previously received delisting notice for MVLS below $35M for 30 consecutive days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224015713/0001493152-24-015713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224015713/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer